NIH begins study of vaccine to mosquito saliva to protect against mosquito-borne diseases
Credit: NIAID
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a Phase 1 clinical trial to test an investigational va..
Ed Rybicki’s insight:
Clever: could provide broad-spectrum defence against a swathe of mosquito-transmitted pathogens.
NIH begins study of vaccine to mosquito saliva to protect against mosquito-borne diseases
Source: Virology News
